Skip to content

Shear Wave Elastography Technology to Evaluate the Efficacy of ESW in the Treatment of Patients With Chronic Plantar Fasciitis

Shear Wave Elastography Technology to Evaluate the Efficacy of ESW in the Treatment of Patients With Chronic Plantar Fasciitis,a Single-blinded Randomised Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05032300
Enrollment
60
Registered
2021-09-02
Start date
2021-11-30
Completion date
2023-12-31
Last updated
2021-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Plantar Fasciitis

Keywords

extracorporeal shock wave, chronic plantar fasciitis, elastic modulus

Brief summary

Inflammation of the plantar fascia is called plantar fasciitis and is common in active or overweight individuals. It can be treated conservatively or surgically. Extracorporeal shock wave therapy has shown significant efficacy in the treatment of plantar fasciitis. Repeated chronic inflammation of the plantar fascia may lead to fibrous edema, thickening and even calcification in the fascia, resulting in thickening of the plantar fascia in patients with chronic plantar fasciitis and affecting the mechanical properties of the plantar fascia (changes in elastic modulus) ). Previous studies rarely involved changes in the elasticity of the plantar fascia before and after extracorporeal shock wave treatment.

Interventions

Procedure: Focused shockwave therapy received shock wave therapy once a week: first locate, touch on the heel of the patient Tenderness points, take tenderness points as treatment points;Then ask the patient to take the lower limbs straight sitting or prone position, Target intensity will be within a range of 0.15-0.25 mJ/mm2 at maximum Hz, Total of 3000 pulses; rest for 20 minutes after the treatment

Stretching and ice massage

Sponsors

Nanfang Hospital, Southern Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Test group (shock wave) chronic plantar fasciitis; Control group patients with chronic plantar fasciitis;

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

1. Pain at the proximal calcaneal stop of the plantar fascia 2. The pain is severe when waking up in the morning or standing and walking after sitting for a long time, and it is slightly relieved after activities, and it will be aggravated after long walking or standing for a long time 3. Pain time\> 3 months 4. Visual Scoring Scale (VAS)\>4 5. The pain is tingling, sore, or burning, etc 6. There is or no tender point at the bottom of the arch of the foot 7. The patient has not undergone corticosteroid injection therapy or shock wave therapy or surgery 8. X-ray confirmed no calcaneal spurs 9. The patient agrees to participate in this study

Exclusion criteria

1. Suffering from calcaneal stress fracture, atrophy of fat pad, compression of the little toe abductor nerve (Baxter's nerve), tarsal tunnel syndrome, sciatica, bone or soft tissue tumor, rheumatism or rheumatoid arthritis, rigidity Those with spondylitis and infection 2. those who disagree with and do not understand the treatment methods or methods of the experiment 3. those with mental disorders

Design outcomes

Primary

MeasureTime frameDescription
Elastic modulus and morphology of plantar fascia lesion areaUp to six monthsSonoelastographic changes of plantar fascia after ESWT
Reduction in pain as assessed by a 0-10 visual analogue scale (VAS)Up to six monthsPatients can score a minimum of 0 and a maximum of 10. Getting a high score indicates a bad situation.

Secondary

MeasureTime frameDescription
American Society of Foot and Ankle Surgery (AOFAS) Ankle and Hindfoot Function ScoreUp to six monthsThe AOFAS assess pain, symptoms, activities of daily living, sports, and quality of life related to foot and ankle pain. This will be assessed on a scale of 0-100, where 100 indicates no problems and 0 indicates extreme problems.

Countries

China

Contacts

Primary Contactyonggang Dou, Master
2206387013@qq.com+8615013006491
Backup Contactqiuyu Chen, Master
168072468@qq.com+8613380057831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026